Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.11143 | 76 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.01214 | 75 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.50191 | 79 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.90453 | 74 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.39322 | 85 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.93541 | 76 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.05838 | 76 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.41683 | 78 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.18452 | 77 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.96219 | 75 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.76254 | 73 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.9001 | 74 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.34227 | 78 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.80581 | 74 |